Chronic wasting disease  by Sigurdson, Christina J. & Aguzzi, Adriano
Biochimica et Biophysica Acta 1772 (2007) 610–618
www.elsevier.com/locate/bbadisReview
Chronic wasting disease
Christina J. Sigurdson ⁎, Adriano Aguzzi
Universitäts Spital Zürich, Institute of Neuropathology, Department of Pathology, Schmelzbergstrasse 12, CH-8091 Zürich, Switzerland
Received 13 July 2006; received in revised form 6 September 2006; accepted 12 October 2006
Available online 18 October 2006Abstract
Until recently, chronic wasting disease of cervids, the only prion disease affecting wildlife, was believed to be geographically concentrated to
Colorado and Wyoming within the United States. However, increased surveillance has unveiled several additional pockets of CWD-infected deer
and elk in 12 additional states and 2 Canadian provinces. Deer and elk with CWD have extensive aggregates of PrPSc not only in the central
nervous system, but also in peripheral lymphoid tissues, skeletal muscle, and other organs, perhaps influencing prion shedding. Indeed, CWD is
transmitted efficiently among animals by horizontal routes, although the mechanism of spread is unknown. Genetic polymorphisms in the Prnp
gene may affect CWD susceptibility, particularly at codon 225 (S/F) in deer and codon 132 (M/L) in elk. Since CWD infects free-ranging animals
and is efficiently spread, disease management will be a challenge.
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A prion disease of free-ranging wildlife, chronic wasting
disease (CWD) affects mule deer (Odocoileus hemionus),
white-tailed deer (O. virginianus), Rocky Mountain elk
(Cervus elaphus nelsoni) [1], and moose (Alces alces shirasi)
[2], all members of the family Cervidae. CWD was first noted
in 1967 within a research facility in Fort Collins, Colorado
where captive mule deer used for nutrition research were
reported with a body wasting syndrome [2]. After more than a
decade of uncertainty about the etiology of CWD, pathologists
Elizabeth Williams and Stewart Young recognized the brain
lesions as those of a transmissible spongiform encephalopathy
(TSE) in 1978, and CWD was subsequently demonstrated as a
prion disease not only by the classic neuronal perikaryonic
vacuoles [3], but also by the accumulation of aggregated prion
protein [4] (Fig. 1) as well as prion infectivity in the brain [5].
In the late 1970s and early 1980s, CWD was detected in two
zoological collections, in Wyoming and in Canada [6].
Beginning in 1981, cases of CWD were discovered in wild
deer and elk on the eastern slope of the Rocky Mountains and⁎ Corresponding author.
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doi:10.1016/j.bbadis.2006.10.010extending out on the plains following river valleys within
Colorado and Wyoming [7,8]. By 1996, CWD was first
detected in Canada's farmed elk, and soon thereafter in the US
elk industry, although it may have occurred in this industry far
earlier. More recently, CWD-infected ranched elk have been
discovered in several other US states and in South Korea
[9,10] raising international awareness and concern regarding
CWD. The origin of CWD remains an enigma (Table 1).
2. Epidemiology and disease management
Based on published and unpublished estimates, there may be
well over 30 million cervids in North America [11]. Prior to
2000, it was known that CWD had spread in part through
transport of captive deer and elk and movements of free-ranging
animals, but its distribution was believed to be limited to a
40,000 km2 region of northern Colorado and southern
Wyoming [1,8], with a small number of cases in Canada
[1,6]. CWD surveillance has recently been initiated in other
states and provinces, and the results have been astonishing.
CWD-infected cervids have been reported in 12 additional
states, extending east to New York and West Virginia, as well as
in 2 Canadian provinces (http://www.aphis.usda.gov/vs/nahps/
cwd/cwd-distribution.html;http://www.nwhc.usgs.gov/disease_
Fig. 1. Immunohistochemistry of mule deer brain and lymphoid tissue using anti-PrP antibody F99/97.6.1 [67]. PrPSc deposits in the brainstem and tonsil from a CWD-
infected mule deer (panels b, d), but not in an uninfected deer (panels a, c).
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map.jsp) (Fig. 2). The distribution pattern is not in contiguous
zones consistent with natural movement of free-ranging
animals, but instead concentrated in focal hotspots of varied
size separated by large distances (Fig. 2). Wisconsin has dense
white-tailed deer populations (15–20 deer/km2) with a
prevalence of up to 13% of the bucks in some regions [12].
The origins of these recent outbreaks remain under investiga-
tion, but in some cases spillover from infected game farms
seems a plausible explanation. The appearance of CWD in wild
cervids presents significant challenges to disease control or
eradication due to (i) the extensive geographic range of North
American deer and elk, (ii) the logistical difficulty in applying
ante-mortem diagnostic tests such as tonsil biopsy [13], and (iii)
the inability to rid the environment of potential prion
contaminated excreta.
CWD surveillance in Europe has been more limited,
however some countries such as Germany have conducted an
active surveillance program. In Germany, a total of 7300 captive
and free-ranging cervids were tested for CWD with no sign of
infection [14]. Reindeer or caribou (Rangifer tarandus), fromTable 1
Inter-ruminant prion transmission experiments
Host Inoculum Exposure route No. of infected/
no. of exposed
Cattle Mule deer CWD+ brain Intracerebral (ic) 5/13
Cattle Cattle CWD from ic infection above Intracerebral 6/6
Elk Sheep scrapie Intracerebral 3/6*
* intercurrent death in 3 animals during first 2 years post-inoculation.North America or Northern Europe respectively, have a highly
homologous prion sequence compared with mule deer, thus are
likely susceptible to CWD. Other European cervids such as
moose and red deer (Cervus elaphus) are also expected to be
CWD-susceptible.
CWD infects free-ranging animals, creating an enormously
complex situation for controlling disease spread, particularly in
light of our poor understanding of specific transmission routes
and susceptibility of non-cervid species. In addition, prion-
infected deer and elk will be consumed by scavengers and
other carnivores, including mountain lions, foxes, raccoons,
coyotes, as well as eagles and vultures. Domestic ruminants
and other herbivores are likely exposed through CWD
contaminated grazing areas, and conversely, wild ruminants
are likely exposed to sheep scrapie. Species known to be
susceptible to CWD by an extreme and unnatural exposure
route, intracerebral inoculation, include ferrets [15], raccoons
[16], other ruminants (discussed below), and squirrel monkeys
[17]. Studies are ongoing to determine whether mountain lions
(Puma concolor) are susceptible (M. Miller, personal commu-
nication and [18]).Time to
terminal disease
Spongiform encephalopathy PrPSc detected by
IHC and/or WB
Reference
2–5 years Equivocal Yes [27]
16.5 months No Yes [29]
3–4 years Yes Yes [31]
Fig. 2. Map depicting the CWD case distribution in North America. (Map kindly provided by the National Wildlife Health Center).
612 C.J. Sigurdson, A. Aguzzi / Biochimica et Biophysica Acta 1772 (2007) 610–6182.1. Transmission among cervids
Of all the mammalian prion diseases, CWD is likely the
most efficiently transmitted. In dense free-ranging deer
populations, CWD prevalence can reach as high as 30%,
however in captive herds, prevalence can climb to nearly
100% [2]. How is CWD transmitted with such efficiency?
This question is arguably one of the biggest conundrums in
the CWD field, and hypotheses range from spread via direct
contact to exposure through grazing in areas contaminated by
prion-infected secretions, excretions (saliva, urine, feces),
tissues (placenta), or decomposed carcasses. Indeed, Miller
et al. have shown that CWD-infected carcasses allowed to
decay naturally in confined pastures can lead to CWD
infections in captive deer [19]. Perhaps multiple exposure
pathways can lead to an infection, nevertheless, horizontal
spread of CWD is clearly occurring [20] and vertical
transmission cannot be excluded. Conceivably the abundant
PrPSc in tonsils and Peyer's patches [4] contributes to PrPSc
shedding in saliva or feces. Nonetheless, environmental prion
contamination underscores the difficulties of CWD eradica-
tion, a goal which is unlikely to be met for free-ranging cervid
populations with the available management techniques.Indeed, CWD eradication is not a stated management goal
for all western states.
Inflammation may increase the risk of prion shedding in
cervids. In prion-infected mice, follicular inflammation in the
kidney directs prions to accumulate within lymphoid follicles
[21] and intriguingly, leads to prion excretion into the urine of
infected mice [22]. Even in natural sheep scrapie cases,
follicular mastitis results in prion accumulation in the mammary
gland [23]. It remains to be seen whether scrapie prions are then
shed into the milk to infect nursing lambs. Because deer and elk
also have a widespread prion assemblage within lymphoid
tissues, it seems plausible that follicular inflammation may also
lead to CWD prion build-up in nonlymphoid organs, potentially
shifting shedding routes. It is unknown whether other types of
inflammation, such as the granulomatous inflammation in the
intestine seen in Johne's disease (Mycobacterium avium subsp.
paratuberculosis) (affects ruminants, including deer and elk) or
parasitic inflammation could lead to or perhaps increase prion
excretion by fecal routes.
Recent studies of prion disease in hamsters indicate the
potential for prion shedding via saliva [24]. In hamsters
intracerebrally (ic) exposed to scrapie, prions are transported
centrifugally from brain to the tongue, and PrPSc deposits in
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potential reservoir for continual PrPSc shedding into saliva. In
addition, PrPSc has been detected in the tongue of 7 of 10 sheep
naturally infected with scrapie using both western blotting and
immunohistochemistry techniques [25]. However, the tongue of
CWD infected deer and elk has not yet been investigated for the
presence of PrPSc or prion infectivity. Nevertheless, CWD-
infected tonsils contain abundant PrPSc (Fig. 1) [26] and may
also serve as a source for prion shedding into saliva. In light of
the commonly shared salt licks and water sources in captivity, as
well as licking behaviors of deer and elk, PrPSc transmission via
saliva should be considered as suspect.
2.2. Transmission to livestock
The capacity for CWD transmission to other species is
clearly an area of great concern since potentially CWD-infected
free-ranging animals are co-habitating with domestic ruminants.
However, data on the risk for other wildlife species or domestic
ruminants contracting the disease is steadily accumulating.
Cattle have been challenged with CWD by 3 routes: (i)
intracerebral (ic), (ii) oral, and (iii) via contact exposure to
CWD-infected mule deer (co-habitation)[25, M. Miller, perso-
nal communication]. After 6 years, only cattle challenged by ic
inoculation have developed disease. Five of thirteen animals
(38%) developed prion infection after an incubation period of
2–5 years [27]. Secondary passage of the cattle CWD led to a
decrease in incubation period to ∼16 months with 100% attack
rate (n=6) [28]. Perhaps surprisingly, cattle did not develop a
spongiform encephalopathy, although PrPSc was clearly
detected in brain by immunohistochemistry and Western blot.
By comparison, ic-induced sheep scrapie infection in cattle
resulted in 100% of cattle developing neurologic disease with
PrPSc deposits in the brain (9/9) [29]. A targeted surveillance of
262 older cattle from a CWD endemic area in Colorado did not
reveal any indication of a TSE [30].
Sheep are also susceptible to CWD after ic inoculation [2],
but have not yet been challenged by oral routes. One goat
developed TSE 6 years after CWD inoculation and showed signs
of intense pruritis and weight loss [6]. Elk have been challenged
with sheep scrapie, and developed a spongiform encephalopathy
with PrPSc in the brain detected by immunohistochemistry and
western blot. Intriguingly, the histologic lesions and PrPSc
deposits in the brain were indistinguishable from CWD in
cervids [31]. As far as we know, deer have not been directly
challenged with sheep scrapie, however this experiment may be
interesting and at least addresses whether sheep scrapie could be
an origin for deer CWD.
2.3. CWD and human susceptibility
Several million deer and elk hunters consume venison in the
US and Canada and there is no doubt that people have been
exposed to CWD. Human susceptibility to CWD is still unclear,
although we can be somewhat reassured in that there have been
no large scale outbreaks with hundreds of human TSE cases in
Colorado and Wyoming, where CWD has existed for decades.That said, diagnosis of potential new TSE strains has been
hampered in that, up until recently, autopsies were not
performed on suspect human TSE cases in many states due to
biosafety concerns. This indicates that clinical TSE diagnoses in
humans were not confirmed, nor was any strain typing done to
look for the appearance of potentially subtle or unusual
pathological or biochemical phenotypes of a new TSE strain.
Fortunately, the autopsy rate for suspect cases is improving. At
the National Prion Disease Pathology Surveillance Center at
Case Western Reserve University (Cleveland, Ohio), CJD
suspect cases are studied and classified by CJD subtype. Thus
far, twenty-seven CJD patients who regularly consumed
venison were reported to the Surveillance Center, however,
there have been no unusual or novel prion subtypes indicating
the appearance of a new prion strain. [11,32].
Other indirect studies of human susceptibility to CWD,
although limited in number, suggest that the risk is low. In
biochemical conversion studies, Caughey et al. showed that the
efficiency of CWD to convert recombinant human PrP into
amyloid fibrils was low, but similar to that of both BSE and
scrapie fibrils to do the same [33]. Recently Xie et al. have
compared histopathology and PrPSc biochemical characteristics
from deer and elk with that of humans with sporadic CJD cases
that are methionine homozygous at codon 129 [34]. The PrPSc
form is cleaved by proteinase-K at different sites depending on
the conformation of the protein so can be used to aid
determination of whether the PrPSc conformation is similar.
For CWD, the unglycosylated PK-resistant PrPSc migrated at 21
kDa, similar to sCJD (MM1 subtype), the PK cleavage site was
the same, occurring at residues 78 and 82 as assessed by N-
terminal sequencing, and the conformational stability also
showed no significant difference between elk CWD and sCJD
MM1 cases. However, there were distinct glycoform patterns
exhibited by two dimensional gel electrophoresis, suggesting
that the elk CWD and human sCJD MM1 strains differ,
although strain features, including histologic profile, target
organs, and glycoform patterns, will not necessarily remain the
same upon crossing species barriers [15,35,36].
Kong et al. studied the question of human susceptibility to
CWD by inoculating transgenic mice expressing human PrP or
elk PrP with elk CWD. Whereas the elk PrP expressing mice
developed disease after only 118–142 days post-inoculation,
human PrP expressing mice (129M) did not develop any
features of TSE after >657 or >756 days [11].
2.4. Cervid prion genetics
The deer and elk primary protein structures are highly
conserved as seen in other mammals. There are four particularly
intriguing features of the deer and elk prion gene. First, a
polymorphism at codon 225 (S/F) may influence CWD
susceptibility. When comparing the frequency of genotypes
among CWD negative and positive free-ranging mule deer
(n=1482), the odds that a CWD-infected animal was 225SS
was 30 times greater when compared to 225SF [37].
Second, elk have a polymorphism at codon 132 (M/L) of
Prnp, corresponding to polymorphic codon 129 (M/V) in
Fig. 3. Superposition of the mean NMR structures of the polypeptide segment
125–229 (C) and 165–172 (D) in ePrP(121–230) (red) and mPrP(121–230)
(blue). A spline function was drawn through the C positions. The radius of the
cylindrical rods representing the polypeptide chains is proportional to the mean
backbone displacement per residue (XX), as evaluated after superposition for
best fit of the atoms N, C, and C′ in the 20 energy-minimized conformers used to
represent the NMR structures [43,68]. Figure provided by Simone Hornemann.
Data published in reference [43].
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reported to be overrepresented among elk with CWD when
compared to uninfected controls [38], and 132LL elk
experimentally infected with CWD have resisted infection for
at least 4 years, whereas 132 MM or 132ML elk (n=2 each)
developed terminal clinical prion disease by 23 or 40 months
post-inoculation, respectively, confirmed by immunohisto-
chemistry and western blot for PrPSc [39].
Third, white-tailed deer also have Prnp polymorphisms
which may affect CWD susceptibility. When the allelic
frequencies from CWD-positive and CWD-negative free-
ranging, Wisconsin white-tailed deer were compared, a G96S
and a Q95H polymorphism were linked to a reduced
susceptibility to CWD [40].
A fourth interesting feature of deer and elk prion genetics
from an evolutionary perspective is the pseudogene which has
been described in mule deer [41] and white-tailed deer [40,42]
(both genus Odocoileus). The pseudogene is suspected to be a
processed retrotransposon, since it lacks introns and is flanked
by direct repeats. In WTD, the pseudogene encodes five or six
octapeptide repeats [42]. At residue 138, the Prnp functional
and pseudogene diverge, encoding a serine or asparagine,
respectively [42]. Neither Old World Rocky Mountain elk nor
New World moose possess the pseudogene, perhaps indicating
that the Prnp pseudogene arose after evolutionary radiation of
Odocoileus in the New World [42].
2.5. Cervid PrP structure
The structure of the elk prion protein has been solved by
NMR analysis of recombinant elk PrP [43] (Fig. 3). When
the elk PrP structure is compared to human or bovine PrP
structures, the global architecture is nearly identical. How-
ever, intriguingly, the elk PrP possesses an extremely well-
defined loop connecting the 2nd alpha helix and beta sheet
(amino acids 166–175), whereas the homologous region is
flexibly disordered in human and bovine PrPC. This loop
region has been studied in detail in the laboratory of Kurt
Wüthrich, as there is an outstandingly high incidence of
nonconservative species variation and the loop is thought to
provide structural insights into species barriers for prion
disease [44]. Further structural studies in 2 mutant mouse PrP
variants derived from the elk PrP primary structure, mPrP
[N174T] and mPrP[S170N, N174T], have confirmed that the
defined loop in the elk is due to 2 amino acid exchanges, as
the mPrP[S170N, N174T] has the conformationally identical
rigid loop of the elk. Whether this loop region confers any
TSE susceptibility or pathologic consequences remains to be
established.
Structural differences clearly influence species susceptibility,
a feature well known for sheep scrapie where susceptibility is
heavily influenced by genotype at codons 136 (V/A), 154 (H/
R), 171 (Q/R) [45]. One proposed etiology of prion disease is
based on a natural propensity for PrP to assume beta-sheet-rich
conformations, in combination with a failure to prevent the
accumulation of the beta-rich isoform, thereby ultimately
leading to aggregated PrP [46,47]. Interestingly, the amyloido-genic site of the yeast prion protein, Sup35, has the same amino
acids as in the loop region of elk PrP, only the sequence order is
different, but possibly suggests an inherent propensity for a
beta-rich conformation with these particular amino acids [48].
Based on this unusual rigid structural feature of the elk PrP, it is
tempting to speculate that the isolated geographic foci of CWD
outbreaks across the U.S. and Canada may be due to increased
risk for a sporadic disease that can then spread horizontally. At
least such possibilities should remain open to discussion.
Another possibility for the isolated outbreaks would be the
undetected spread of CWD through commerce of captive
cervids.
2.6. Clinical disease and lesions in natural cases
Deer and elk with CWD show subtle signs of disease,
characterized byweight loss, isolation from the herd, hypersaliva-
tion, polydipsia/polyuria, frequent regurgitation±esophageal
distension, and rarely ataxia [49] (Fig. 4). The clinical signs are
nonspecific and difficult to detect in early stages except by those
working daily with the animals. In one report, a captive herd of
133 white-tailed deer was discovered with 50% CWD positive in
brain or lymphoid tissue, though no clinical signs were noted by
the landowner or hunters [42]. The clinical course varies from
several weeks to up to many months [50].
Necropsy findings include subacute to chronic bronchop-
neumonia (likely due to aspiration), froth or watery rumen
contents (often containing sand), abomasal or omasal ulcers,
serous atrophy of bone marrow and pericardial fat, enlarged
adrenal glands, and muscle atrophy [7].
Histopathologic lesions in the brain are similar to those
described for BSE in cattle and scrapie in sheep and goats:
perikaryonic neuronal vacuoles, microcavitation of gray matter,
astrogliosis, neuronal degeneration and loss, and PrPSc
positively labeled prion deposits and plaques. Target areas for
severe spongiform change included olfactory bulb and stria,
Fig. 4. Mule deer with clinical signs of CWD including hypersalivation, a lowered head, emaciation, and a dry, rough hair coat (panel a). A clinically normal control
mule deer is shown for comparison (panel b).
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tegmental nuclei, and nuclei within the medulla oblongata,
including neurons of the reticular formation, as well as nuclei
from the hypoglossal, vagal, medial and lateral cuneatus, and
spinal tract of the trigeminal nerve [4,7,50]. Neuropathology
varies slightly between deer and elk: elk have more severe
lesions in the thalamus and in some white matter areas [50].
Congo red bifringent, PAS-positive amyloid plaques have been
seen in deer brain but not elk [50].
2.7. Pathogenesis
Transmission of CWD into deer and elk demonstrated CWD
as a prion disease, with spongiform change and PrP amyloid
fibrils in the brain of inoculated animals [2,6]. Oral CWD
infection of mule deer fawns indicates that PrPSc appears at
early timepoints in the retropharyngeal lymph node, tonsil, and
Peyer's patches by 3 months post-feeding [51]. At terminal
stages of disease, PrPSc accumulates in part in the intestinal
plexi and vagus nerve, although the timing of prion infection of
ganglia and nerves is not known [52].
CWD is one of several prion diseases in which PrPSc is
typically disseminated throughout the lymphoid system prior to
the CNS. Thus, tonsil biopsy can be used to diagnose CWD
ante-mortem, although a negative tonsil biopsy does not rule out
CWD infection as not all follicles are necessarily positive
[51,53] and not all CWD cases have a lymphoid phase of
infection. This scenario is seen particularly in elk, where 28/226
CWD positive elk in one study did not have detectable PrPSc in
the lymphoid system [54]. PrPSc in lymphoid tissue co-localizes
with follicular dendritic cell (FDC) and tingible body macro-
phage markers [55], as seen with natural sheep scrapie and
experimental mouse scrapie [56,57]. In mouse scrapie models,
C1q is essential for peripheral PrPSc replication, and C1q
deficiency leads to a marked delay in incubation period,
suggesting that the classical complement cascade is an
important early step in prion pathogenesis [58,59]. The
mechanism by which C1q interacts with PrPSc and the
connection with accumulation on FDCs is unresolved, but
may also have relevance for CWD pathogenesis.
Early stages of oral uptake of prions across the intestinal
mucosa of sheep have been recently examined in greater detailby Jeffrey et al. [60]. Loops of intestine were isolated and
inoculated with prions. PrPSc was detected in the dilated villous
lacteals and submucosal lymphatics by 3 h post-inoculation,
within dendritic-like cells in the draining lymph node by 24 h,
and in the Peyer's patches by 30 days post-inoculation. Uptake
was not affected by the Prnp genotype of the sheep. It is not
known precisely when and how prion infectivity enters nerves, or
whether PrP amplication in the Peyer's patches is a prerequisite
for nerve entry, although Mabbott et al. have shown in mice that
prion infection of Peyer's patches does not impact the kinetics of
CNS infection after 14 days post-oral challenge [61].
In studies by Spraker et al., PrPSc accumulation in the brain
has been characterized in great detail in MD, WTD, and elk,
both captive and free-ranging [4,7,54]. Experimental CWD time
course studies are underway but have not yet been published to
characterize the pathogenesis, therefore it remains unclear when
and how prion infectivity reaches the brain and spinal cord.
However, natural CWD cases in MD have been classified by
PrPSc and spongiform encephalopathy distribution throughout
the brain [62]. PrPSc consistently accumulated in the brainstem,
particularly the dorsal motor nucleus of the vagus. Other organs
that accumulate PrPSc in mule deer include adrenal glands,
pancreatic islets, and pituitary [52].
2.8. New tools for CWD investigation
A big leap forward for CWD research occurred with the
development of cervid PrP expressing transgenic mice
(CerTgPrP), recently described by Browning et al. to be highly
susceptible to CWD infection [5]. Mice develop plaques in the
brain resembling CWD in cervids. Thus far, prion infectivity in
various organs of cervids has not yet been examined in detail by
bioassay, however, CWD infectivity has been recently shown in
skeletal muscle of naturally CWD-infected deer [63]. A second
cervid PrP transgenic mouse has been described by Kong et al.
[11].
A CWD-susceptible cell line has been developed derived
from cervid brain fibroblasts, and has been used to screen
inhibitors of CWD infection, e.g., pentosan polysulfate [64].
This is the first CWD specific assay introduced for screening
compounds that inhibit CWD propagation. Perhaps these cells
will also be useful to assess CWD infectivity.
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In sheep scrapie, many strains of TSEs exist, including an
‘atypical scrapie’ known as Nor98 [65]. For CWD, the existence
of multiple strains is unclear. Transgenic mice overexpressing
murine PrP and inoculated with CWD develop a mixture of
pathological and biochemical phenotypes which may suggest
the existence of multiple strains, although the phenotypic
variability could also be due to strain adaptation [69]. Safar et al.
reported differing conformational characteristics for CWD from
WTD and elk using a conformation dependent assay (CDI),
which is also suggestive of strain differences [66].
In light of the discussion herein, one aspect of CWD research
is crystal clear: there are many unsolved mysteries in this
disease of wild animals. The sooner we understand basic disease
factors such as CWD origins, mechanisms of spread, and
species susceptibility, the more specifically we can target
prevention and management programs.
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